Swissmedic – pharmaceutical daily

June 20, 2017 Off

Swissmedic to review Takeda, TiGenix’s Chron’s disease treatment Cx601

Takeda and TiGenix reported on Tuesday that the Swiss Agency for Therapeutic Products (Swissmedic) has accepted for review the file on investigational compound Cx601 to treat complex perianal fistulas in patients with Crohn’s disease.

November 23, 2015 Off

Geistlich Pharma recalls Decalcit chewing tablets due to Italian version typo

By Dino Mustafić

The Swiss-based company Geistlich Pharma AG is recalling batch of Decalcit, vitamin D and calcium chewable tablets, from the market.

September 29, 2015 Off

Switzerland: Suspected crime connected with medicinal products. Swissmedic investigates

By Dino Mustafić

Several individuals in German-speaking Switzerland are suspected of offences against the Therapeutic Products Act.